Pooneh Mokarram
Overview
Explore the profile of Pooneh Mokarram including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
983
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rahmani-Kukia N, Keshavarzi F, Salehi M, Bozorg-Ghalati F, Mojtahedi Z, Zamani M, et al.
Mol Biol Res Commun
. 2025 Mar;
14(2):167-175.
PMID: 40028474
Human Epidermal Neural Crest Stem Cells (hEPI-NCSCs), as a transient population of multipotent migratory stem cells can differentiate into multiple types of neural and non-neural cells and tissues in the...
2.
Dastghaib S, Shafiee S, Ramezani F, Ashtari N, Tabasi F, Saffari-Chaleshtori J, et al.
Eur J Pharmacol
. 2024 Dec;
988():177210.
PMID: 39706466
The development of chemo-resistance remains a significant hurdle in effective cancer therapy. NRF1 and NRF2, key regulators of redox homeostasis, play crucial roles in the cellular response to oxidative stress,...
3.
Zamani M, Sadeghi E, Mokarram P, Kadkhodaei B, Ghasemi H
Int J Radiat Biol
. 2024 Dec;
101(3):232-239.
PMID: 39625853
Background: Resistance to chemo- and radiotherapy is the main obstacle in cancer treatment success, which results in cancer's poor prognosis. Therefore finding the exact mechanism of resistance may contribute to...
4.
Ahmadpour F, Igder S, Eftekhari Moghadam A, Moradipoodeh B, Sepahdar A, Mokarram P, et al.
Int J Mol Cell Med
. 2024 Nov;
13(3):272-285.
PMID: 39493516
Breast cancer, characterized by genetic diversity and molecular subtypes, presents significant treatment challenges, especially in human epidermal growth factor receptor type 2 (HER2)-positive cases, which are associated with poor prognosis....
5.
Zamani M, Safari F, Siri M, Igder S, Khatami N, Dastghaib S, et al.
J Cancer Res Clin Oncol
. 2024 Oct;
150(10):474.
PMID: 39441422
Purpose: Colorectal cancer (CRC) remains a global health challenge with limited treatment success due to drug resistance. Recent research highlights the potential of small molecules to modulate CRC by targeting...
6.
Mokarram P, Ghavami S
Biochim Biophys Acta Mol Basis Dis
. 2024 Jun;
1870(7):167289.
PMID: 38871032
No abstract available.
7.
Rezayi S, Siri M, Rahmani-Kukia N, Zamani M, Dastghaib S, Mokarram P
Mol Biol Rep
. 2024 Apr;
51(1):599.
PMID: 38689181
Background: CPUK02 (15-Oxosteviol benzyl ester) is a semi-synthetic derivative of stevioside known for its anticancer effects. It has been reported that the natural compound of stevioside and its associated derivatives...
8.
Dastghaib S, Shojaei S, Mostafavi-Pour Z, Sharma P, Patterson J, Samali A, et al.
Cells
. 2024 Apr;
13(8).
PMID: 38667338
In the original publication [...].
9.
Bagheri Lankarani K, Sadidoost A, Fattahi M, Fard S, Mokarram P
Iran J Med Sci
. 2024 Apr;
49(3):196-200.
PMID: 38584654
Despite antiviral treatment, some patients with chronic hepatitis B (CHB) progress to cirrhosis. Enhancement of autophagy was implicated in the proliferation of hepatitis B in hepatocytes. This study aimed to...
10.